ARTICLE
|
doi:10.20944/preprints202306.0059.v1
Subject:
Medicine And Pharmacology,
Epidemiology And Infectious Diseases
Keywords:
COVID-19; SARS-CoV-2; remdesivir; nirmatrelvir; variant; synergy; antiviral; immunosuppressed
Online: 1 June 2023 (08:00:38 CEST)